BRIEF—WuXi STA opens new production facility in China

WuXi AppTec subsidiary WuXi STA has begun operations at a new flow chemistry plant in Changzhou, China, for large-scale production of active pharmaceutical ingredients (API).

An addition to the company’s existing campus, the expansion represents part of a strategic move to meet growing manufacturing demand.

The company now has multiple flow chemistry R&D labs and 25 continuous manufacturing lines at a range of locations in China.

Chief technical officer Xiaoyong Fu said: "We are witnessing a fast-growing customer demand driven by the extensive application of flow chemistry in the pharmaceutical industry."

He added: "As a trusted partner and a global enabler, we will continue to strengthen our flow chemistry platform and accelerate new therapeutics with safer and more cost-effective solutions.”